Elena Bonfiglioli, a seasoned healthcare executive, joins electroCore's Board of Directors, bringing extensive experience from Microsoft and startups.
electroCore focuses on bioelectronic technologies for health improvement, offering non-invasive solutions for chronic pain and wellness promotion.
The appointment reflects electroCore's commitment to enhancing corporate governance and driving growth with accomplished leadership.
Key Appointment
Elena Bonfiglioli appointed to electroCore's Board of Directors, adding valuable expertise from global healthcare and technology sectors.
Mission Statement
electroCore aims to enhance health and quality of life through innovative bioelectronic technologies, focusing on non-invasive neuromodulation for chronic pain management.
Product Portfolio
The Company offers gammaCore nVNS and Quell neurostimulator for chronic pain treatment, alongside Truvaga and TAC-STIM nVNS products for general wellness.
- Elena Bonfiglioli's appointment strengthens electroCore's leadership team, bringing diverse industry knowledge and strategic insights.
- The addition of a healthcare industry veteran like Bonfiglioli signals electroCore's intent to drive market expansion and pursue innovation in non-invasive healthcare solutions.
The appointment of Elena Bonfiglioli underscores electroCore's strategic focus on growth and innovation in the bioelectronic medicine sector, positioning the company for continued success in addressing healthcare challenges.